1-2 of 2
Jose Angel Mendez, MD
Close
Sort by
Journal Articles

Comparison of Efficacy and Safety of Two Types of E.coli Asparaginase (Native or Pegylated) for Treatment of Adult Patients with High-Risk (HR), Philadelphia (Ph) Chromosome-Negative ALL Included in the Prospective MRD-Oriented Protocol ALL-HR-11 from the Spanish Pethema Group

Josep-Maria Ribera, MD PhD, Mireia Morgades, MProbS, Pau Montesinos, MD PhD, Irene García-Cadenas, MD, Pere Barba, MD PhD, Beatriz Soria, MD, Arancha Bermúdez, MªJosé Moreno, MD, José González-Campos, MD, Susana Vives, MD, Cristina Gil, MD, Eugenia Abella, MD PhD, Ramon Guàrdia, MD PhD, Teresa Bernal, MD PhD, Pilar Martínez-Sánchez, MD, MªLuz Amigo, MD, Santiago Mercadal, MD, Alfons Serrano, MD, Aurelio López-Martínez, MD, Ferran Vall-llovera, MD, MªJosé Sánchez-Sánchez, MD, MªJesús Peñarrubia, MD PhD, María Calbacho, MD, Jose-Angel Méndez, MD, Juan Bergua, MD, Antònia Cladera, MD, Mar Tormo, MD, Daniel García-Belmonte, MD, Juana Ciudad, MD PhD, Evarist Feliu, MD PhD, Alberto Orfao, MD PhD
Journal: Blood
Blood (2016) 128 (22): 180.
https://doi.org/10.1182/blood.V128.22.180.180
Published: 2016
Journal Articles

Impact of Velaglucerase Alfa in the Inflammatory Status of Type 1 Gaucher Disease Patients after One Year on Therapy. A Prospective Multicentre Study

Marcio Andrade-Campos, MD, Javier Gervas, PhD, Inmaculada García-Jiménez, MD, Olga Salamero, Pedro Martinez-Odriozola, MD, Jose Angel Mendez, MD, Fernando Garcia-Bragado, MD, Cristina Fernandez-Canal, MD, Luis Ignacio Sancho-Val, PhD, Horacio Cano, MD, Jordi Perez-Lopez, MD, Jesus Maria Hernandez-Rivas, PhD, Juan Francisco Lorenzo, MD, Miguel Lopez-Dupla, MD, Virginia Callao, PhD, Pilar Giraldo, PhD
Journal: Blood
Blood (2015) 126 (23): 4606.
https://doi.org/10.1182/blood.V126.23.4606.4606
Published: 2015